We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Oral Cannabidiol Effect on Blood Pressure in Hypertensive Patients (HYPER-H21-4)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT05346562
Recruitment Status : Active, not recruiting
First Posted : April 26, 2022
Last Update Posted : April 26, 2022
Lexaria Bioscience Corp
University of British Columbia
University of Colorado, Denver
Information provided by (Responsible Party):
Zeljko Dujic, University of Split, School of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 5, 2022
Estimated Study Completion Date : April 5, 2023